| Todd Michael Barbosa, | |
|
1817a Madison St, Ste 1, Clarksville, TN 37043-2930 | |
| (931) 551-1795 | |
| (931) 551-1798 |
| Full Name | Todd Michael Barbosa |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 17 Years |
| Location | 1817a Madison St, Clarksville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417114588 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 46896 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Memorial Hospital San Buenaventura | Ventura, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ventura Anesthesia Medical Group | 0648260836 | 33 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel therapeutic strategy, called adaptive therapy, which is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells.
A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.
Further to advice issued by the RACGP and the Chief Medical Officer, NPS is encouraging health professionals to offer their patients influenza vaccination, especially for those at risk, but to be aware that the choice of influenza vaccine is important, especially for children.
› Verified 7 days ago
| Entity Name | Ventura Anesthesia Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164465159 PECOS PAC ID: 0648260836 Enrollment ID: O20040518000863 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel therapeutic strategy, called adaptive therapy, which is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells.
A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.
Further to advice issued by the RACGP and the Chief Medical Officer, NPS is encouraging health professionals to offer their patients influenza vaccination, especially for those at risk, but to be aware that the choice of influenza vaccine is important, especially for children.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Michael Barbosa, 2900 Old Clarksville Spgfld Rd, Adams, TN 37010-8905 Ph: (805) 794-4636 | Todd Michael Barbosa, 1817a Madison St, Ste 1, Clarksville, TN 37043-2930 Ph: (931) 551-1795 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel therapeutic strategy, called adaptive therapy, which is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells.
A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.
Further to advice issued by the RACGP and the Chief Medical Officer, NPS is encouraging health professionals to offer their patients influenza vaccination, especially for those at risk, but to be aware that the choice of influenza vaccine is important, especially for children.
› Verified 7 days ago
Sarah Eisen Ellis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 647 Dunlop Ln, Suite 305, Clarksville, TN 37040 Phone: 931-802-5515 Fax: 931-802-5518 | |
Joe S Holt, D.D.S Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1771 Madison St, Clarksville, TN 37043 Phone: 931-551-1795 Fax: 931-551-1798 | |
Jatin K Kadakia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 311 Landrum Pl, Suite 700, Clarksville, TN 37043 Phone: 931-648-8314 Fax: 931-647-3841 | |
Dr. Vidya R Bethi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 482 Warfield Blvd, Clarksville, TN 37043 Phone: 931-906-6644 Fax: 931-906-7805 |